Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...

A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...

A wide range of foods will be affected if the Food and Drug Administration (FDA) moves forward with plans to ban artificial ...

Dilantin is available in capsule, chewable pill, oral solution, and IV form. This drug interacts with nerve cell sodium channels. Sodium channels facilitate normal nerve activity, and excessive ...

The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer ...

With Trump back in the White House, will FDA policies on psychedelics shift? What's the impact on mental health care and ...

Groundbreaking studies in mice have sparked a frenzy among longevity enthusiasts—but human trials are still in their infancy.

CMS launches an outcomes-based model to expand access to FDA-approved gene therapies for sickle cell disease, aiming to ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

The U.S. Food and Drug Administration has approved PTC Therapeutics' Kebilidi (eladocagene exuparvovec-tneq) for the ...

Adverse drug reactions (ADRs) and medication adherence are critical aspects of healthcare, particularly within pediatric and obstetric fields. Pediatric patients and pregnant women are often more ...

New: Gift this subscriber-only story to your friends and family Join ST's Telegram channel and get the latest breaking news delivered to you.